tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aligos Therapeutics Reports Q2 2025 Progress and Results
PremiumCompany AnnouncementsAligos Therapeutics Reports Q2 2025 Progress and Results
1M ago
Aligos Therapeutics reports Q2 EPS ($1.53), consensus ($2.54)
Premium
The Fly
Aligos Therapeutics reports Q2 EPS ($1.53), consensus ($2.54)
1M ago
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
Premium
The Fly
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
2M ago
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
PremiumThe FlyAligos Therapeutics announces inducement grants under Nasdaq listing rule
4M ago
Aligos Therapeutics presents data at EASL Congress 2025
Premium
The Fly
Aligos Therapeutics presents data at EASL Congress 2025
4M ago
Aligos Therapeutics Reports Strong Q1 2025 Progress
Premium
Company Announcements
Aligos Therapeutics Reports Strong Q1 2025 Progress
4M ago
Aligos Therapeutics files to sell 6.25M shares of common stock for holders
PremiumThe FlyAligos Therapeutics files to sell 6.25M shares of common stock for holders
5M ago
Aligos Therapeutics presents positive data at APASL2025
Premium
The Fly
Aligos Therapeutics presents positive data at APASL2025
6M ago
Ten option delistings on March 24th
Premium
The Fly
Ten option delistings on March 24th
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100